The Journal of Clinical Investigation (Oct 2023)

Zfp335 establishes eTreg lineage and neonatal immune tolerance by targeting Hadha-mediated fatty acid oxidation

  • Xin Wang,
  • Lina Sun,
  • Biao Yang,
  • Wenhua Li,
  • Cangang Zhang,
  • Xiaofeng Yang,
  • Yae Sun,
  • Xiaonan Shen,
  • Yang Gao,
  • Bomiao Ju,
  • Yafeng Gao,
  • Dan Liu,
  • Jiapeng Song,
  • Xiaoxuan Jia,
  • Yanhong Su,
  • Anjun Jiao,
  • Haiyan Liu,
  • Lianjun Zhang,
  • Lan He,
  • Lei Lei,
  • WanJun Chen,
  • Baojun Zhang

Journal volume & issue
Vol. 133, no. 20

Abstract

Read online

Regulatory T cells (Tregs) are instrumental in maintaining immune tolerance and preventing destructive autoimmunity, but how heterogeneous Treg populations are established remains largely unknown. Here, we show that Zfp335 deletion in Tregs failed to differentiate into effector Tregs (eTregs) and lose Treg-suppressive function and that KO mice exhibited early-onset lethal autoimmune inflammation with unrestricted activation of conventional T cells. Single-cell RNA-Seq analyses revealed that Zfp335-deficient Tregs lacked a eTreg population and showed dramatic accumulation of a dysfunctional Treg subset. Mechanistically, Zfp335-deficient Tregs displayed reduced oxidative phosphorylation and dysfunctional mitochondrial activity. Further studies revealed that Zfp335 controlled eTreg differentiation by regulating fatty acid oxidation (FAO) through direct targeting of the FAO enzyme Hadha. Importantly, we demonstrate a positive correlation between ZNF335 and HADHA expression in human eTregs. Our findings reveal that Zfp335 controls FAO-driven eTreg differentiation to establish immune tolerance.

Keywords